Clinical trials: Hyperkalemia, Diminished Renal Excretion

Hyperkalemia, Diminished Renal Excretion

Evidence for Potassium Restriction in Hemodialysis

• Active, not recruiting
• Age: 18 years and older
• Lifestyle or therapy programme

EvoKe-HD is a pilot randomized controlled trial to assess the feasibility and potential for efficacy of a novel dietary approach to hyperkalemia.

Trial name

EvoKe-HD (NCT06120608)

Testing

Novel dietary approach focused on restricting the intake of highly bioavailable potassium, Traditional approach

Where

Canada

Volunteers

50 people

Sponsor

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal